Join us for this online webinar on Wednesday 12 May and find out about a unique opportunity for the antibiotic community. The Innovative Medicines Initiative’s GNA NOW Consortium is looking for a novel antibiotic compound to progress to a clinical candidate. To find out more about what the Consortium is looking for, what’s in it for interested candidates, and how to submit a proposal, join the upcoming GNA NOW webinar on Wednesday 12 May from 10:00-11:00 (CEST).
Hosted by Lygature as coordinator of the GNA NOW Consortium, the event will take place viaMicrosoft Teams. Discussions with attendees will form a key part of the session and time will be made available for questions and answers.
About GNA NOW
Established in July 2019, the GNA NOW Consortium is a European collaboration of 11 partners focused on progressing Gram-Negative antibiotics from lead optimization to the completion of Phase I trials. Working under the AMR Accelerator umbrella, the project is funded by the Innovative Medicines Initiative (IMI) with in kind contributions from industry partner, Evotec.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853979. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
This communication reflects the views of the GNA NOW Consortium and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein.
For questions regarding registration, feel free to contact the GNA NOW programme office at: email@example.com